DAO and schizophrenia: Nevertheless, this variability does raise the issue of the general applicability of the findings; inspection of the raw data shows that the increased cerebellar DAO immunoreactivity and mRNA in schizophrenia, whilst seen in both the London and Oxford series, was more apparent in the former (Table 2).